Home

News & Blog - developing
Weekly Digest: WHO approves semi-synthetic artemisinin, antibiotic preservation - a joint responsibility, and funding for AMFm
17 May 2013
A roundup of news on drug resistance and other topics in global health.Stressing the need to preserve the efficacy of antibiotics, CDDEP Director Ramanan Laxminarayan writes in CDC’s Safe Healthcare that “we are all responsible for whether future generations will have effective antibiotics.” [CDC]
Read more »
0 Comments
Posted by Suraj Pant
Tags: AMFm, antibiotic use, antibiotics, developing, disease, drug development, drug resistance, flu, health economics, India, MRSA, new antibiotics, new drugs, policy, prescribing, resistance, TB
Weekly digest: Resistance in wildlife, malaria-proof mosquitoes, and the cost of infectious disease
10 May 2013
A roundup of news on drug resistance and other topics in global health.
Read more »
0 Comments
Posted by Suraj Pant
Tags: ACTs, AMFm, animal use, antibiotic use, antibiotics, cost, data visualization, developing, disease, disease mapping, drug development, drug resistance, food safety, HAIs, health, health economics, India, malaria ecology, MRSA, new antibiotics, new drugs, prescribing, resistance, resistance policy, transmission, trends
World Malaria Day 2013: Malaria in Review
25 Apr 2013
This post was written in collaboration with CDDEP researcher Suraj Pant.
Read more »
0 Comments
Posted by Alison Buki
Tags: ACTs, AMFm, community, cost, counterfeit drugs, developing, disease, disease ecology, disease mapping, drug development, drug resistance, ecology, elimination, health, health economics, malaria ecology, malaria mapping, malaria vaccine, MFTs, mobile health, multiple first-line therapies, new drugs, policy, resistance, resistance ecology, resistance policy, transmission, trends
Weekly digest: The future of MRSA, stopping drug-resistant TB, and malaria drugs from yeast
12 Apr 2013
A roundup of news on drug resistance and other topics in global health. How has the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) changed over the past decade, and what does the future hold? CDDEP blogs. [CDDEP]
Read more »
0 Comments
Posted by Suraj Pant
Tags: ACTs, Agriculture, animal use, antibiotic use, antibiotics, cost, data visualization, developing, disease, drug development, drug resistance, HAIs, health, health economics, India, MRSA, prescribing, resistance, TB, trends
Weekly digest: Preserving antimalarial effectiveness, Resistance: the film, and resistant bacteria in pigs
15 Feb 2013
A  roundup of news on drug resistance and other topics in global health.
Read more »
0 Comments
Posted by Suraj Pant
Tags: ACTs, Agriculture, AMFm, animal use, antibiotic use, antibiotics, community, cost, costs, counterfeit drugs, developing, disease, disease ecology, disease mapping, drug development, drug resistance, elimination, HAIs, health economics, malaria ecology, malaria mapping, malaria vaccine, MRSA, multiple first-line therapies, resistance, resistance ecology, resistance policy, TB